Literature DB >> 34970721

Detection of human herpesviruses in cerebrospinal fluids collected from patients suspected of neuroinfectious diseases.

Soichiro Ishimaru1, Yoshiki Kawamura2, Hiroki Miura1, Sayuri Shima3, Akihiro Ueda3, Hirohisa Watanabe3, Tatsuro Mutoh3, Tetsushi Yoshikawa1.   

Abstract

The full spectrum of human herpesviruses (HHV)-associated neuroinfectious diseases in immunocompetent adults remains unclear. Hence, we sought to elucidate the epidemiology and clinical features of these diseases. The study subjects were patients over 16 years old suspected of neuroinfectious diseases who underwent spinal tap performed by neurologists in our university hospital between April 2013 and March 2018. The presence of seven HHV DNAs in cerebrospinal fluid (CSF) was determined by real-time PCR. HHV DNAs were detected in 33 (10.2%) of the 322 patients. The most frequently detected herpesvirus was varicella zoster virus (VZV) (19 patients), followed by HHV-6 (four patients), herpes simplex virus (HSV)-1 (three patients), HSV-2 (three patients), and Epstein-Barr virus (two patients). HHV DNAs were detected in CSF collected from patients with various neuroinfectious diseases, including myelitis, peripheral neuritis, encephalitis, and meningitis. All patients with HSV-1 DNA had encephalitis, whereas all patients with HSV-2 DNA had meningitis. Eleven of the 19 patients with VZV DNA had meningitis. Patients with VZV-associated encephalitis (median age, 80 years) were significantly older than non-encephalitis patients (median age, 60.5 years) (P = 0.046). Although post-herpetic neuralgia was observed in seven (54%) of the 13 patients with VZV and without encephalitis, no such neurological sequela was observed in the four encephalitis patients. In conclusion, HHVs were associated with approximately 10% of neuroinfectious diseases in this cohort. VZV was the most common pathogen, probably due to the large number of VZV meningitis patients. In addition, patients with VZV-associated meningitis were significantly younger than patients with VZV-associated encephalitis.
© 2021. Journal of NeuroVirology, Inc.

Entities:  

Keywords:  Central nervous system infection; Cerebrospinal fluid; Human herpesviruses; Real-time PCR

Mesh:

Substances:

Year:  2021        PMID: 34970721     DOI: 10.1007/s13365-021-01040-5

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  39 in total

1.  Human herpesvirus-6 encephalitis associated with hypersensitivity syndrome.

Authors:  Vincent Descamps; Sophie Collot; Nadhira Houhou; Sylvie Ranger-Rogez
Journal:  Ann Neurol       Date:  2003-02       Impact factor: 10.422

2.  Severity of human herpesvirus-6 viremia and clinical findings in infants with exanthem subitum.

Authors:  Y Asano; T Nakashima; T Yoshikawa; S Suga; T Yazaki
Journal:  J Pediatr       Date:  1991-06       Impact factor: 4.406

3.  Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.

Authors:  Marc C Chamberlain; Sajeel Chowdhary
Journal:  Neurology       Date:  2008-02-05       Impact factor: 9.910

4.  A case of acute polyradiculoneuropathy, drug-induced hypersensitivity, and HHV-6 infection.

Authors:  C Del Borgo; S Zaniratti; C Minosse; A Vetica; A Bellini; F Soscia; P Missori; F Pierelli; A Currà
Journal:  Neurology       Date:  2009-03-10       Impact factor: 9.910

5.  Viral infections of the central nervous system in Spain: a prospective study.

Authors:  F de Ory; A Avellón; J E Echevarría; M P Sánchez-Seco; G Trallero; M Cabrerizo; I Casas; F Pozo; G Fedele; D Vicente; M J Pena; A Moreno; J Niubo; N Rabella; G Rubio; M Pérez-Ruiz; M Rodríguez-Iglesias; C Gimeno; J M Eiros; S Melón; M Blasco; I López-Miragaya; E Varela; A Martinez-Sapiña; G Rodríguez; M Á Marcos; M I Gegúndez; G Cilla; I Gabilondo; J M Navarro; J Torres; C Aznar; A Castellanos; M E Guisasola; A I Negredo; A Tenorio; S Vázquez-Morón
Journal:  J Med Virol       Date:  2012-12-12       Impact factor: 2.327

6.  Severe meningoencephalitis caused by human herpesvirus 6 type B in an immunocompetent woman treated with ganciclovir.

Authors:  Tobias Birnbaum; Claudio S Padovan; Bernd Sporer; Tobias A Rupprecht; Harald Ausserer; Gundula Jaeger; Hans W Pfister
Journal:  Clin Infect Dis       Date:  2005-02-21       Impact factor: 9.079

7.  Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency.

Authors:  Akifumi Endo; Ken Watanabe; Tamae Ohye; Kyoko Suzuki; Tomoyo Matsubara; Norio Shimizu; Hiroki Kurahashi; Tetsushi Yoshikawa; Harutaka Katano; Naoki Inoue; Kohsuke Imai; Masatoshi Takagi; Tomohiro Morio; Shuki Mizutani
Journal:  Clin Infect Dis       Date:  2014-05-06       Impact factor: 9.079

8.  Sequence analysis of transplacentally acquired human herpesvirus 6 DNA is consistent with transmission of a chromosomally integrated reactivated virus.

Authors:  Annie Gravel; Caroline Breese Hall; Louis Flamand
Journal:  J Infect Dis       Date:  2013-02-13       Impact factor: 5.226

9.  Predominant human herpesvirus 6 variant A infant infections in an HIV-1 endemic region of Sub-Saharan Africa.

Authors:  Matthew Bates; Mwaka Monze; Humphrey Bima; Mirriam Kapambwe; David Clark; Francis C Kasolo; Ursula A Gompels
Journal:  J Med Virol       Date:  2009-05       Impact factor: 2.327

10.  Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome.

Authors:  Yasuhiro Fujino; Masashi Nakajima; Hirosato Inoue; Tomohiko Kusuhara; Tatsuo Yamada
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.